These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided? Schlag PM Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128 [TBL] [Abstract][Full Text] [Related]
3. Regional lymph node dissections in malignant melanoma. Lawton GP; Ariyan S Clin Plast Surg; 2000 Jul; 27(3):431-40, ix. PubMed ID: 10941563 [TBL] [Abstract][Full Text] [Related]
4. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998. Fisher SR Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046 [TBL] [Abstract][Full Text] [Related]
7. Surgical management of patients with intermediate thickness melanoma: current role of elective lymph node dissection. Cole DJ; Baron PL Semin Oncol; 1996 Dec; 23(6):719-24. PubMed ID: 8970593 [TBL] [Abstract][Full Text] [Related]
8. Regional lymph node dissection for malignant melanoma of the extremities. Roses DF; Harris MN; Gumport SL; Michelassi F; Coffey JA; Dubin N Surgery; 1981 Jun; 89(6):654-9. PubMed ID: 7245026 [TBL] [Abstract][Full Text] [Related]
9. [Surgical and adjuvant drug therapy in head and neck cutaneous melanoma]. Hauschild A; Lischner S; Christophers E Laryngorhinootologie; 2000 Jul; 79(7):428-33. PubMed ID: 11005097 [TBL] [Abstract][Full Text] [Related]
10. Elective lymph node dissection in melanoma: still a controversial issue. Kroon BB; Jonk A Neth J Surg; 1991 Aug; 43(4):129-32. PubMed ID: 1944991 [TBL] [Abstract][Full Text] [Related]
11. Controversies in the management of metastatic melanoma to regional lymphatic basins. Mack LA; McKinnon JG J Surg Oncol; 2004 Jul; 86(4):189-99. PubMed ID: 15221926 [TBL] [Abstract][Full Text] [Related]
13. Neck dissection: then and now. Ferlito A; Rinaldo A; Silver CE; Shah JP; Suárez C; Medina JE; Kowalski LP; Johnson JT; Strome M; Rodrigo JP; Werner JA; Takes RP; Towpik E; Robbins KT; Leemans CR; Herranz J; Gavilán J; Shaha AR; Wei WI Auris Nasus Larynx; 2006 Dec; 33(4):365-74. PubMed ID: 16889923 [TBL] [Abstract][Full Text] [Related]
14. The case for wide local excision and regional node dissection for high-risk cutaneous melanoma. Karakousis CP Curr Opin Gen Surg; 1993; ():303-9. PubMed ID: 7583999 [TBL] [Abstract][Full Text] [Related]
15. Melanoma in children and the use of sentinel lymph node biopsy. Bütter A; Hui T; Chapdelaine J; Beaunoyer M; Flageole H; Bouchard S J Pediatr Surg; 2005 May; 40(5):797-800. PubMed ID: 15937817 [TBL] [Abstract][Full Text] [Related]
16. [Risk factors for lymph node metastasis in malignant melanoma]. Mussack T; Waldner H; Kharraz-Tavakol A Zentralbl Chir; 1996; 121(6):465-8. PubMed ID: 8767332 [TBL] [Abstract][Full Text] [Related]
17. [Prognosis of malignant melanoma following dissection regional lymph node metastases]. Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406 [TBL] [Abstract][Full Text] [Related]
18. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3). Nowecki ZI; Rutkowski P; Michej W Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535 [TBL] [Abstract][Full Text] [Related]
19. Investment in new technology research can save future health care dollars. Reintgen D; Albertini J; Milliotes G; Marshburn J; Cruse CW; Rapaport D; Berman C; Glass F; Fensske N; Einstein AB; Lyman G J Fla Med Assoc; 1997 Mar; 84(3):175-81. PubMed ID: 9143169 [TBL] [Abstract][Full Text] [Related]
20. The case for minimal margins and delayed regional node dissection for high-risk cutaneous melanoma. Cascinelli N; Belli F Curr Opin Gen Surg; 1993; ():310-5. PubMed ID: 7584000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]